Report Overview
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
The global Peptide Vaccine market size was estimated at USD 3683 million in 2023 and is projected to reach USD 5379.73 million by 2032, exhibiting a CAGR of 4.30% during the forecast period.
North America Peptide Vaccine market size was estimated at USD 1031.73 million in 2023, at a CAGR of 3.69% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Peptide Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Vaccine market in any manner.
Global Peptide Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Market Segmentation (by Type)
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Market Segmentation (by Application)
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptide Vaccine Market
Overview of the regional outlook of the Peptide Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide Vaccine
1.2 Key Market Segments
1.2.1 Peptide Vaccine Segment by Type
1.2.2 Peptide Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peptide Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Peptide Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peptide Vaccine Market Competitive Landscape
3.1 Global Peptide Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Peptide Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Peptide Vaccine Sales Sites, Area Served, Product Type
3.6 Peptide Vaccine Market Competitive Situation and Trends
3.6.1 Peptide Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peptide Vaccine Industry Chain Analysis
4.1 Peptide Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peptide Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peptide Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Peptide Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Peptide Vaccine Price by Type (2019-2025)
7 Peptide Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Vaccine Market Sales by Application (2019-2025)
7.3 Global Peptide Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Peptide Vaccine Sales Growth Rate by Application (2019-2025)
8 Peptide Vaccine Market Consumption by Region
8.1 Global Peptide Vaccine Sales by Region
8.1.1 Global Peptide Vaccine Sales by Region
8.1.2 Global Peptide Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Peptide Vaccine Market Production by Region
9.1 Global Production of Peptide Vaccine by Region (2019-2025)
9.2 Global Peptide Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Peptide Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Peptide Vaccine Production
9.4.1 North America Peptide Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Peptide Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Peptide Vaccine Production
9.5.1 Europe Peptide Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Peptide Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Peptide Vaccine Production (2019-2025)
9.6.1 Japan Peptide Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Peptide Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Peptide Vaccine Production (2019-2025)
9.7.1 China Peptide Vaccine Production Growth Rate (2019-2025)
9.7.2 China Peptide Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Anergis
10.1.1 Anergis Peptide Vaccine Basic Information
10.1.2 Anergis Peptide Vaccine Product Overview
10.1.3 Anergis Peptide Vaccine Product Market Performance
10.1.4 Anergis Business Overview
10.1.5 Anergis Peptide Vaccine SWOT Analysis
10.1.6 Anergis Recent Developments
10.2 Antigen Express
10.2.1 Antigen Express Peptide Vaccine Basic Information
10.2.2 Antigen Express Peptide Vaccine Product Overview
10.2.3 Antigen Express Peptide Vaccine Product Market Performance
10.2.4 Antigen Express Business Overview
10.2.5 Antigen Express Peptide Vaccine SWOT Analysis
10.2.6 Antigen Express Recent Developments
10.3 Apitope Technology
10.3.1 Apitope Technology Peptide Vaccine Basic Information
10.3.2 Apitope Technology Peptide Vaccine Product Overview
10.3.3 Apitope Technology Peptide Vaccine Product Market Performance
10.3.4 Apitope Technology Peptide Vaccine SWOT Analysis
10.3.5 Apitope Technology Business Overview
10.3.6 Apitope Technology Recent Developments
10.4 Artificial Cell Technologies
10.4.1 Artificial Cell Technologies Peptide Vaccine Basic Information
10.4.2 Artificial Cell Technologies Peptide Vaccine Product Overview
10.4.3 Artificial Cell Technologies Peptide Vaccine Product Market Performance
10.4.4 Artificial Cell Technologies Business Overview
10.4.5 Artificial Cell Technologies Recent Developments
10.5 Benovus Bio
10.5.1 Benovus Bio Peptide Vaccine Basic Information
10.5.2 Benovus Bio Peptide Vaccine Product Overview
10.5.3 Benovus Bio Peptide Vaccine Product Market Performance
10.5.4 Benovus Bio Business Overview
10.5.5 Benovus Bio Recent Developments
10.6 Celgene Corporation
10.6.1 Celgene Corporation Peptide Vaccine Basic Information
10.6.2 Celgene Corporation Peptide Vaccine Product Overview
10.6.3 Celgene Corporation Peptide Vaccine Product Market Performance
10.6.4 Celgene Corporation Business Overview
10.6.5 Celgene Corporation Recent Developments
10.7 Immatics biotechnologies
10.7.1 Immatics biotechnologies Peptide Vaccine Basic Information
10.7.2 Immatics biotechnologies Peptide Vaccine Product Overview
10.7.3 Immatics biotechnologies Peptide Vaccine Product Market Performance
10.7.4 Immatics biotechnologies Business Overview
10.7.5 Immatics biotechnologies Recent Developments
10.8 Merck
10.8.1 Merck Peptide Vaccine Basic Information
10.8.2 Merck Peptide Vaccine Product Overview
10.8.3 Merck Peptide Vaccine Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 ImmunoCellular Therapeutics
10.9.1 ImmunoCellular Therapeutics Peptide Vaccine Basic Information
10.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Overview
10.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product Market Performance
10.9.4 ImmunoCellular Therapeutics Business Overview
10.9.5 ImmunoCellular Therapeutics Recent Developments
10.10 ISA Pharmaceuticals
10.10.1 ISA Pharmaceuticals Peptide Vaccine Basic Information
10.10.2 ISA Pharmaceuticals Peptide Vaccine Product Overview
10.10.3 ISA Pharmaceuticals Peptide Vaccine Product Market Performance
10.10.4 ISA Pharmaceuticals Business Overview
10.10.5 ISA Pharmaceuticals Recent Developments
10.11 Lytix Biopharma
10.11.1 Lytix Biopharma Peptide Vaccine Basic Information
10.11.2 Lytix Biopharma Peptide Vaccine Product Overview
10.11.3 Lytix Biopharma Peptide Vaccine Product Market Performance
10.11.4 Lytix Biopharma Business Overview
10.11.5 Lytix Biopharma Recent Developments
10.12 Spotlight Innovation
10.12.1 Spotlight Innovation Peptide Vaccine Basic Information
10.12.2 Spotlight Innovation Peptide Vaccine Product Overview
10.12.3 Spotlight Innovation Peptide Vaccine Product Market Performance
10.12.4 Spotlight Innovation Business Overview
10.12.5 Spotlight Innovation Recent Developments
10.13 OncoTherapy Science
10.13.1 OncoTherapy Science Peptide Vaccine Basic Information
10.13.2 OncoTherapy Science Peptide Vaccine Product Overview
10.13.3 OncoTherapy Science Peptide Vaccine Product Market Performance
10.13.4 OncoTherapy Science Business Overview
10.13.5 OncoTherapy Science Recent Developments
10.14 Peptech
10.14.1 Peptech Peptide Vaccine Basic Information
10.14.2 Peptech Peptide Vaccine Product Overview
10.14.3 Peptech Peptide Vaccine Product Market Performance
10.14.4 Peptech Business Overview
10.14.5 Peptech Recent Developments
10.15 Pharmasyntez
10.15.1 Pharmasyntez Peptide Vaccine Basic Information
10.15.2 Pharmasyntez Peptide Vaccine Product Overview
10.15.3 Pharmasyntez Peptide Vaccine Product Market Performance
10.15.4 Pharmasyntez Business Overview
10.15.5 Pharmasyntez Recent Developments
10.16 Sumitomo Dainippon Pharma
10.16.1 Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
10.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
10.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product Market Performance
10.16.4 Sumitomo Dainippon Pharma Business Overview
10.16.5 Sumitomo Dainippon Pharma Recent Developments
10.17 TapImmune
10.17.1 TapImmune Peptide Vaccine Basic Information
10.17.2 TapImmune Peptide Vaccine Product Overview
10.17.3 TapImmune Peptide Vaccine Product Market Performance
10.17.4 TapImmune Business Overview
10.17.5 TapImmune Recent Developments
10.18 Targovax
10.18.1 Targovax Peptide Vaccine Basic Information
10.18.2 Targovax Peptide Vaccine Product Overview
10.18.3 Targovax Peptide Vaccine Product Market Performance
10.18.4 Targovax Business Overview
10.18.5 Targovax Recent Developments
11 Peptide Vaccine Market Forecast by Region
11.1 Global Peptide Vaccine Market Size Forecast
11.2 Global Peptide Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peptide Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Peptide Vaccine Market Size Forecast by Region
11.2.4 South America Peptide Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Peptide Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Peptide Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Peptide Vaccine by Type (2025-2032)
12.1.2 Global Peptide Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Peptide Vaccine by Type (2025-2032)
12.2 Global Peptide Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Peptide Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Peptide Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Peptide Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Peptide Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Peptide Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Peptide Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2022)
Table 10. Global Market Peptide Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Peptide Vaccine Sales Sites and Area Served
Table 12. Manufacturers Peptide Vaccine Product Type
Table 13. Global Peptide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide Vaccine Market Challenges
Table 22. Global Peptide Vaccine Sales by Type (K MT)
Table 23. Global Peptide Vaccine Market Size by Type (M USD)
Table 24. Global Peptide Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Peptide Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Peptide Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Peptide Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Peptide Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Peptide Vaccine Sales (K MT) by Application
Table 30. Global Peptide Vaccine Market Size by Application
Table 31. Global Peptide Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Peptide Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Peptide Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Peptide Vaccine Market Share by Application (2019-2025)
Table 35. Global Peptide Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Peptide Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Peptide Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Peptide Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Peptide Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Peptide Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Peptide Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Peptide Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Peptide Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Peptide Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Peptide Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Peptide Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Anergis Peptide Vaccine Basic Information
Table 52. Anergis Peptide Vaccine Product Overview
Table 53. Anergis Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Anergis Business Overview
Table 55. Anergis Peptide Vaccine SWOT Analysis
Table 56. Anergis Recent Developments
Table 57. Antigen Express Peptide Vaccine Basic Information
Table 58. Antigen Express Peptide Vaccine Product Overview
Table 59. Antigen Express Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Antigen Express Business Overview
Table 61. Antigen Express Peptide Vaccine SWOT Analysis
Table 62. Antigen Express Recent Developments
Table 63. Apitope Technology Peptide Vaccine Basic Information
Table 64. Apitope Technology Peptide Vaccine Product Overview
Table 65. Apitope Technology Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Apitope Technology Peptide Vaccine SWOT Analysis
Table 67. Apitope Technology Business Overview
Table 68. Apitope Technology Recent Developments
Table 69. Artificial Cell Technologies Peptide Vaccine Basic Information
Table 70. Artificial Cell Technologies Peptide Vaccine Product Overview
Table 71. Artificial Cell Technologies Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Artificial Cell Technologies Business Overview
Table 73. Artificial Cell Technologies Recent Developments
Table 74. Benovus Bio Peptide Vaccine Basic Information
Table 75. Benovus Bio Peptide Vaccine Product Overview
Table 76. Benovus Bio Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Benovus Bio Business Overview
Table 78. Benovus Bio Recent Developments
Table 79. Celgene Corporation Peptide Vaccine Basic Information
Table 80. Celgene Corporation Peptide Vaccine Product Overview
Table 81. Celgene Corporation Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Celgene Corporation Business Overview
Table 83. Celgene Corporation Recent Developments
Table 84. Immatics biotechnologies Peptide Vaccine Basic Information
Table 85. Immatics biotechnologies Peptide Vaccine Product Overview
Table 86. Immatics biotechnologies Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Immatics biotechnologies Business Overview
Table 88. Immatics biotechnologies Recent Developments
Table 89. Merck Peptide Vaccine Basic Information
Table 90. Merck Peptide Vaccine Product Overview
Table 91. Merck Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Merck Business Overview
Table 93. Merck Recent Developments
Table 94. ImmunoCellular Therapeutics Peptide Vaccine Basic Information
Table 95. ImmunoCellular Therapeutics Peptide Vaccine Product Overview
Table 96. ImmunoCellular Therapeutics Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. ImmunoCellular Therapeutics Business Overview
Table 98. ImmunoCellular Therapeutics Recent Developments
Table 99. ISA Pharmaceuticals Peptide Vaccine Basic Information
Table 100. ISA Pharmaceuticals Peptide Vaccine Product Overview
Table 101. ISA Pharmaceuticals Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. ISA Pharmaceuticals Business Overview
Table 103. ISA Pharmaceuticals Recent Developments
Table 104. Lytix Biopharma Peptide Vaccine Basic Information
Table 105. Lytix Biopharma Peptide Vaccine Product Overview
Table 106. Lytix Biopharma Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Lytix Biopharma Business Overview
Table 108. Lytix Biopharma Recent Developments
Table 109. Spotlight Innovation Peptide Vaccine Basic Information
Table 110. Spotlight Innovation Peptide Vaccine Product Overview
Table 111. Spotlight Innovation Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Spotlight Innovation Business Overview
Table 113. Spotlight Innovation Recent Developments
Table 114. OncoTherapy Science Peptide Vaccine Basic Information
Table 115. OncoTherapy Science Peptide Vaccine Product Overview
Table 116. OncoTherapy Science Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. OncoTherapy Science Business Overview
Table 118. OncoTherapy Science Recent Developments
Table 119. Peptech Peptide Vaccine Basic Information
Table 120. Peptech Peptide Vaccine Product Overview
Table 121. Peptech Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Peptech Business Overview
Table 123. Peptech Recent Developments
Table 124. Pharmasyntez Peptide Vaccine Basic Information
Table 125. Pharmasyntez Peptide Vaccine Product Overview
Table 126. Pharmasyntez Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Pharmasyntez Business Overview
Table 128. Pharmasyntez Recent Developments
Table 129. Sumitomo Dainippon Pharma Peptide Vaccine Basic Information
Table 130. Sumitomo Dainippon Pharma Peptide Vaccine Product Overview
Table 131. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Sumitomo Dainippon Pharma Business Overview
Table 133. Sumitomo Dainippon Pharma Recent Developments
Table 134. TapImmune Peptide Vaccine Basic Information
Table 135. TapImmune Peptide Vaccine Product Overview
Table 136. TapImmune Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. TapImmune Business Overview
Table 138. TapImmune Recent Developments
Table 139. Targovax Peptide Vaccine Basic Information
Table 140. Targovax Peptide Vaccine Product Overview
Table 141. Targovax Peptide Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Targovax Business Overview
Table 143. Targovax Recent Developments
Table 144. Global Peptide Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 145. Global Peptide Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 146. North America Peptide Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 147. North America Peptide Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 148. Europe Peptide Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 149. Europe Peptide Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 150. Asia Pacific Peptide Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 151. Asia Pacific Peptide Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 152. South America Peptide Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 153. South America Peptide Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 154. Middle East and Africa Peptide Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 155. Middle East and Africa Peptide Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 156. Global Peptide Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 157. Global Peptide Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 158. Global Peptide Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 159. Global Peptide Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 160. Global Peptide Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Peptide Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Peptide Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Peptide Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide Vaccine Market Size by Country (M USD)
Figure 11. Peptide Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Peptide Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide Vaccine Market Share by Type
Figure 18. Sales Market Share of Peptide Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Peptide Vaccine by Type in 2023
Figure 20. Market Size Share of Peptide Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Peptide Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide Vaccine Market Share by Application
Figure 24. Global Peptide Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Peptide Vaccine Sales Market Share by Application in 2023
Figure 26. Global Peptide Vaccine Market Share by Application (2019-2025)
Figure 27. Global Peptide Vaccine Market Share by Application in 2023
Figure 28. Global Peptide Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Peptide Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Peptide Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Peptide Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Peptide Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Peptide Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Peptide Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Peptide Vaccine Sales Market Share by Region in 2023
Figure 44. China Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Peptide Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Peptide Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Peptide Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Peptide Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Peptide Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Peptide Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Peptide Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Peptide Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Peptide Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Peptide Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Peptide Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Peptide Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Peptide Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Peptide Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Peptide Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Peptide Vaccine Market Share Forecast by Application (2025-2032)
